IL107754A - Stabilised superoxide dismutase (sod) compositions their preparation and pharmaceutical formulations containing them - Google Patents

Stabilised superoxide dismutase (sod) compositions their preparation and pharmaceutical formulations containing them

Info

Publication number
IL107754A
IL107754A IL10775493A IL10775493A IL107754A IL 107754 A IL107754 A IL 107754A IL 10775493 A IL10775493 A IL 10775493A IL 10775493 A IL10775493 A IL 10775493A IL 107754 A IL107754 A IL 107754A
Authority
IL
Israel
Prior art keywords
cyclodextrin
superoxide dismutase
solution
sod
composition
Prior art date
Application number
IL10775493A
Other languages
English (en)
Other versions
IL107754A0 (en
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of IL107754A0 publication Critical patent/IL107754A0/xx
Publication of IL107754A publication Critical patent/IL107754A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
    • C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
    • C12Y115/01001—Superoxide dismutase (1.15.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
IL10775493A 1992-11-27 1993-11-25 Stabilised superoxide dismutase (sod) compositions their preparation and pharmaceutical formulations containing them IL107754A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4239877A DE4239877C1 (de) 1992-11-27 1992-11-27 Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung

Publications (2)

Publication Number Publication Date
IL107754A0 IL107754A0 (en) 1994-02-27
IL107754A true IL107754A (en) 1996-10-16

Family

ID=6473780

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10775493A IL107754A (en) 1992-11-27 1993-11-25 Stabilised superoxide dismutase (sod) compositions their preparation and pharmaceutical formulations containing them

Country Status (16)

Country Link
US (1) US5464614A (en, 2012)
EP (1) EP0599262A3 (en, 2012)
JP (1) JPH06199691A (en, 2012)
KR (1) KR940011014A (en, 2012)
AU (1) AU671495B2 (en, 2012)
CA (1) CA2110087A1 (en, 2012)
DE (1) DE4239877C1 (en, 2012)
FI (1) FI935264A7 (en, 2012)
HU (1) HUT65580A (en, 2012)
IL (1) IL107754A (en, 2012)
MX (1) MX9307433A (en, 2012)
NO (1) NO934289L (en, 2012)
NZ (1) NZ250285A (en, 2012)
PH (1) PH30788A (en, 2012)
TW (1) TW252046B (en, 2012)
ZA (1) ZA938848B (en, 2012)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719479B1 (fr) * 1994-05-04 1996-07-26 Sanofi Elf Formulation stable lyophilisée comprenant une protéine: kit de dosage.
US5876992A (en) 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
US6132712A (en) * 1996-12-11 2000-10-17 A. Glenn Braswell Superoxide dismutase stabilized with fragments of casein and pharmaceutical compositions incorporating same
BR9807537B1 (pt) * 1997-01-30 2009-01-13 composição liofilizada de fator humano morfogenético ósseo mp52, bem como processo para sua preparação.
US20040132653A1 (en) * 1997-01-30 2004-07-08 Biopharm Gmbh Lyophilized composition of bone morphogenetic factor human MP52
US20030022243A1 (en) * 2001-06-20 2003-01-30 Les Kondejewski Protein aggregation assays and uses thereof
DE10223783A1 (de) * 2002-05-29 2003-12-11 Boehringer Ingelheim Pharma Neue Formulierung zur parenteralen Applikation eines Na-Kanal-Blockers
US8318803B2 (en) * 2003-10-31 2012-11-27 Tae-Yoon Kim EC SOD and use thereof
KR100676502B1 (ko) * 2003-10-31 2007-02-02 김태윤 Ｅｃ ｓｏｄ 및 세포 침투성 ｅｃ ｓｏｄ와 이들의 용도
KR101010055B1 (ko) * 2008-06-16 2011-01-21 한국전력공사 디스크 유량계 및 그의 제어방법
WO2011041584A2 (en) 2009-09-30 2011-04-07 President And Fellows Of Harvard College Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products
RU2664691C2 (ru) * 2012-10-26 2018-08-21 Люпин Лимитед Стабильная фармацевтическая композиция на основе слитого белка tnfr:fc
EP3091069A1 (en) 2015-05-06 2016-11-09 Fitoplancton Marino S.L. Method for obtaining a biomass of a microalga of the species tetraselmis chuii enriched in superoxide dismutase (sod)

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5712993A (en) * 1980-06-23 1982-01-22 Fujirebio Inc Isolation of superoxide dismutase
IT1142524B (it) * 1981-05-27 1986-10-08 Serono Ist Farm Composizione farmaceutica contenente orgoteina
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
HU189251B (en) * 1982-04-07 1986-06-30 Asahi Kasei Kogyo Kk,Jp Process for stabilizing tumor necrosis factor
EP0123291A2 (en) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
DE3486452T2 (de) * 1983-10-03 1997-11-06 Chiron Corp., Emeryville, Calif. Superoxiddismutase und deren Expression in Mikroorganismen
JPS60155133A (ja) * 1983-11-09 1985-08-15 シンビオテイツクス　コ−ポレイシヨン アンチ−イデイオタイプのモノクロナル抗体を採用したアンチ−イデイオタイプワクチン
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
CA1340597C (en) * 1984-08-27 1999-06-22 Haim Aviv Expression vectors containing pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods
JPS61111690A (ja) * 1984-11-06 1986-05-29 Ube Ind Ltd 組換えｄｎａおよびその用途
CA1232850A (en) * 1985-01-17 1988-02-16 Albert D. Friesen Purification of superoxide dismutase
ES8800982A1 (es) * 1985-07-05 1987-12-01 Takeda Chemical Industries Ltd Un metodo para producir la enzima superoxido-dismutasa modificada con derivados de polietilenglicol y triazina.
DK402785D0 (da) * 1985-09-03 1985-09-03 Syn Tek Ab Fremgangsmaade til fremstilling af et enzym
JPS6279778A (ja) * 1985-10-04 1987-04-13 Suntory Ltd 新規ス−パ−オキシドデイスムタ−ゼ及びその製造方法
IE59498B1 (en) * 1985-11-22 1994-03-09 Bio Technology General Corp Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form
US5246847A (en) * 1985-11-22 1993-09-21 Bio-Technology General Corp. Polypeptide analogs of human manganese superoxide dismutase and compositions and complexes thereof
US4933433A (en) * 1986-01-31 1990-06-12 E. I. Du Pont De Nemours And Company Recombinant interleukin-2 composition and process for making it
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
EP0284105B1 (en) * 1987-03-27 1995-11-15 Bio-Technology General Corporation Human manganese superoxide dismutase and methods of treatment
DE3851257D1 (de) * 1987-05-21 1994-10-06 Suntory Ltd Azyliertes Derivat von Superoxid-Dismutase und dieses enthaltende Zusammensetzung.
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
JPH01304882A (ja) * 1988-06-03 1989-12-08 Ube Ind Ltd ヒトＣｕ，Ｚｎ型スーパーオキシドジスムターゼの安定保存法
JP2942578B2 (ja) * 1988-06-14 1999-08-30 カイロン コーポレイション 新しい結合特性を有する超酸化物不均化酵素類縁体
JPH0610138B2 (ja) * 1988-07-12 1994-02-09 日本化薬株式会社 スーパーオキシドディスムターゼ組成物
US5538878A (en) * 1988-08-08 1996-07-23 Calgene, Inc. Superoxide dismutase expression in plants
EP0359617A3 (en) * 1988-09-02 1990-04-04 Plant Genetic Systems, N.V. Stress-tolerant plants
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
IL96136A (en) * 1989-11-07 2000-12-06 Bio Technology General Corp Use of hydrophobic chromatography in a method for purification of copper-zinc superoxide dismutase from cells containing same
JPH0568541A (ja) * 1990-12-28 1993-03-23 Asahi Chem Ind Co Ltd 活性なエクストラセルラー・スーパーオキシドジスムターゼの製造方法
US5298410A (en) * 1993-02-25 1994-03-29 Sterling Winthrop Inc. Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life

Also Published As

Publication number Publication date
EP0599262A3 (de) 1994-11-23
JPH06199691A (ja) 1994-07-19
NO934289L (no) 1994-05-30
IL107754A0 (en) 1994-02-27
TW252046B (en, 2012) 1995-07-21
DE4239877C1 (de) 1994-03-17
US5464614A (en) 1995-11-07
EP0599262A2 (de) 1994-06-01
HUT65580A (en) 1994-07-28
AU671495B2 (en) 1996-08-29
ZA938848B (en) 1995-04-06
KR940011014A (ko) 1994-06-20
FI935264L (fi) 1994-05-28
FI935264A7 (fi) 1994-05-28
NO934289D0 (no) 1993-11-26
CA2110087A1 (en) 1994-05-28
HU9303365D0 (en) 1994-03-28
NZ250285A (en) 1995-04-27
MX9307433A (es) 1994-08-31
AU5195393A (en) 1994-06-09
FI935264A0 (fi) 1993-11-26
PH30788A (en) 1997-10-17

Similar Documents

Publication Publication Date Title
US5464614A (en) Stabilized superoxide dismutase (SOD) composition
ES2368061T3 (es) Composiciones farmacéuticas de toxina botulínica.
KR100266145B1 (ko) G-csf의 안정한 동결건조된 약제학적 제제
US4767874A (en) Stable freeze-dried preparations of an anticancer platinum complex
US5334382A (en) Lyophilized polyethylene oxide modified catalase composition, polypeptide complexes with cyclodextrin and treatment of diseases with the catalase compositions
JP3530300B2 (ja) 安定なトランスグルタミナーゼ製剤およびそれらを製造する方法
ES2349472T3 (es) Formulación estable de interferón pegilado.
BG106578A (bg) Фармацевтични състави на фибринолитичен агент
KR20140037932A (ko) 안정화된 보리코나졸 조성물
HU228877B1 (en) Formulations for stabilization of peg-interferon alpha conjugates and method for preparation such formulations
JP3100058B2 (ja) 線維芽細胞成長因子を含む安定な医薬組成物
HU218216B (hu) Stabil, liofilizált tiotepa készítmény
US7744904B1 (en) Stabilization of Clostridium botulinum neurotoxin complex
CN116650425B (zh) 糖酯化合物或其盐在冷冻保护、冷冻干燥保护中的应用
FR2910812A1 (fr) Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
JP2024028905A (ja) ペグアスパラガーゼの凍結乾燥組成物
EP3622959A1 (en) Cyclodextrin for protecting cells upon cryopreservation
ES2988461T3 (es) Composición farmacéutica que comprende condroitinasa ABC liofilizada, envase y procedimiento de fabricación de los mismos
KR100840164B1 (ko) 프로스타글란딘 함유 동결 건조품
RU2517211C2 (ru) Фармацевтическая композиция, содержащая фермент дезоксирибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония или дикалия или тринатрия
RU2831537C2 (ru) Лекарственная форма лиофилизированного состава ботулинического токсина, доступная для долгосрочного хранения
TW202527913A (zh) 冷凍乾燥之羥基尿素甲基醯基富烯
HK1250140B (en) Method for producing a freeze-dried pharmaceutical composition containing mitomycin c
EP4257120A1 (en) Fosphenytoin sodium solid composition, lyophilization method, and use of fosphenytoin sodium solid composition
WO2021181010A1 (fr) Composition pour le traitement de lesions du système respiratoire

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
RH Patent void